Beam Therapeutics, Inc. (BEAM)
30.96
-0.26
(-0.82%)
USD |
NASDAQ |
Jan 20, 16:00
31.21
+0.24
(+0.79%)
After-Hours: 05:30
Beam Therapeutics Market Cap: 3.142B for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Intellia Therapeutics, Inc. | 1.486B |
| Twist Bioscience Corp. | 2.552B |
| ANI Pharmaceuticals, Inc. | 1.926B |
| Pacific Biosciences of California, Inc. | 712.50M |
| Regeneron Pharmaceuticals, Inc. | 77.12B |
Market Cap Related Metrics
| PS Ratio | 52.17 |
| PEG Ratio | -0.046 |
| Price to Book Value | 3.253 |
| Price | 30.96 |
| Earnings Yield | -14.32% |
| PEGY Ratio | -0.046 |